After going on a shopping spree around the state and buying 23 products from 10 dispensaries, researchers from the University of Northern Colorado had the products tested at a commercial cannabis lab – and the results were at odds with the products’ labels.
In a press conference on April 12, the country’s health minister, Karl Lauterbach, announced that cannabis will be available via non-profit clubs, at least initially.
The Washington State Liquor and Cannabis Board announced that its staff had identified “a pattern of pesticide testing failures” among cannabis cultivators in the Okanogan region.
The study found that the number of stores per capita had increased by an average of 122% each year since legalization, with per capita sales also increasing by 91% per year.
The recalled products were sold between March 14 to March 24, 2023, throughout Ontario.
The researchers observed “a shift from negative and sensationalist cannabis news coverage toward more balanced and progressive framing” over the study period.
On Friday morning, March 31, the state’s governor, Andy Beshear, signed Senate Bill 47, legalizing the use and sale of medical cannabis (although sales aren’t expected to begin until 2025).
From now on, flower products will have to be tested for potency by cannabis labs – something that wasn’t required before.
Oklahoma’s cannabis regulator has denied a business application to a company following a judge’s ruling that the business submitted fraudulent ownership information.
State regulators in Colorado have issued two more health and safety notices after “potentially unsafe levels” of total yeast and mold and Aspergillus were found in certain pre-roll cigarettes and batches of cannabis flower.